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CHD7 Maintains Neural Stem Cell Quiescence and
Prevents Premature Stem Cell Depletion in the
Adult Hippocampus
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ABSTRACT
Neural stem/progenitor cells (NSCs) in the hippocampus produce new neurons throughout adult
life. NSCs are maintained in a state of reversible quiescence and the failure to maintain the qui-
escent state can result in the premature depletion of the stem cell pool. The epigenetic mecha-
nisms that maintain this quiescent state have not been identified. Using an inducible knockout
mouse model, we show that the chromatin remodeling factor chromodomain–helicase-DNA-
binding protein 7 (CHD7) is essential for maintaining NSC quiescence. CHD7 inactivation in adult
NSCs results in a loss of stem cell quiescence in the hippocampus, a transient increase in cell
divisions, followed by a significant decline in neurogenesis. This loss of NSC quiescence is associ-
ated with the premature loss of NSCs in middle-aged mice. We find that CHD7 represses the
transcription of several positive regulators of cell cycle progression and is required for full
induction of the Notch target gene Hes5 in quiescent NSCs. These findings directly link CHD7 to
pathways involved in NSC quiescence and identify the first chromatin-remodeling factor with a
role in NSC quiescence and maintenance. As CHD7 haplo-insufficiency is associated with a range
of cognitive disabilities in CHARGE syndrome, our observations may have implications for under-
standing the basis of these deficits. STEM CELLS 2015;33:196–210
INTRODUCTION
New neurons are continuously generated from
neural stem/progenitor cells (NSCs) that reside in
discrete regions of the adult mammalian fore-
brain [1–5]. NSCs located in the subgranular zone
(SGZ) of the dentate gyrus (DG) divide infre-
quently and produce new neurons after transiting
through a rapidly proliferating transit amplifying
progenitor stage [1, 5]. Newborn granule cells
produced in the DG are capable of integrating
into existing circuitry and play an important role
in certain types of hippocampus-dependent
learning tasks and memory formation [6–9].
Quiescence is a reversible state of growth
arrest crucial for the preservation of somatic
stem cell number and function [10–15]. Failure to
maintain quiescence can result in the accelerated
conversion of stem cells to progenitors and deple-
tion of the stem cell pool [10, 15]. For example,
deletion of RBPJ (recombination signal binding
protein for immunoglobulin kappa J region), the
downstream effector of Notch signaling, or the
Notch1 receptor itself, leads to a loss of NSC qui-
escence, a rapid depletion of the stem cell pool,
and an irreversible deficit in neurogenesis
[16–18]. Similarly, loss of the cyclin-dependent
kinase inhibitors p21 or p57 and cell cycle inhibi-
tor Btg1, all cause an increase in NSC proliferation
and the eventual depletion of the stem cell pool
that has been ascribed to proliferative exhaustion
of the quiescent NSC pool [13, 19, 20].
Chromatin remodeling factors can alter the
accessibility of DNA to the transcriptional
machinery through the eviction of nucleo-
somes, initiating nucleosome sliding, or by facil-
itating DNA looping [21]. Chromatin remodeling
factors play important roles in stem cell func-
tion and daughter cell differentiation; however,
whether they have a role in regulating NSC qui-
escence is not known [22, 23]. Chromodomain–
helicase-DNA-binding protein 7 (CHD7) is a
member of the CHD family of ATP-dependent
chromatin-remodeling enzymes [24]. Recent
studies have identified a role for CHD7 in
embryonic NSC function [25], and adult NSC dif-
ferentiation [26]. Furthermore, CHD7 has been
shown to interact with the NSC regulator SOX2
to regulate target gene transcription in fetal
neural stem cells [27].
Using genetic mouse models and an in
vitro quiescence assay, we have found that
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CHD7 deletion in NSCs results in a loss of stem cell quies-
cence and a transient increase in immature neuron formation,
before an eventual decline in neurogenesis. Interestingly, loss
of stem cell quiescence after deletion of CHD7 in adult NSCs
leads to a large decrease in the number of NSCs in the hippo-
campus of middle-aged mice as the stem cell pool is
depleted. We find that loss of CHD7 results in the misregula-
tion of genes involved in cell cycle progression and Notch sig-
naling, directly linking CHD7 to pathways with established
roles in NSC quiescence.
MATERIALS AND METHODS
Animals
Adult CD1 mice were obtained from Charles River, U.K.
GLAST:: CreERT2 [28], Nestin-Cre [29], and Rosa-EYFP (RYFP)
[30] mice have been described previously. Mice with Chd7
exon 3 flanked by LoxP sites (Chd7tm2a(EUCOMM)Wtsi) were gen-
erated from an ES clone (Emma ID, EM:04817 Cell line,
EPD0019_1_D07), hereinafter designated the Chd7f allele. Fol-
lowing Flpe-mediated removal of the b-geo cassette by cross-
ing to Tg(ACTFLPe)9205Dym, the conditional allele was
validated using Tg(ACTB-cre)2Mrt to create and phenocopy a
constitutively null allele (P.J. Scambler, unpublished
observations).
All experiments were initiated in adult mice between 10
and 12 weeks of age. All animal procedures were approved
by the U.K. Home Office. GLAST::CreERT2;Chd7f/f or GLAST::
CreERT2;Chd7f/f;RYFP/1 mice were used to delete Chd7 from
adult NSCs upon tamoxifen (TAM) administration. Chd7f/f or
Chd7f/f;RYFP/1 mice were used as controls throughout. We
confirmed that TAM-treated GLAST::CreERT2;RYFP/1 mice
exhibited identical phenotypes to other control mice, ruling
out any effects from Cre toxicity or nonspecific effects of
TAM.
In Vitro Cell Culture and FACS Isolation
Fetal-derived NSCs from a mating between Nestin-Cre;Chd7f/1
and Chd7f/f mice were isolated from the cortex and striatum
of E16.5 embryos. After genotyping, cultures from Nestin-
Cre;Chd7f/f embryos and Cre-negative embryos were estab-
lished. Cell growth and quiescence conditions were as
described previously [31–35]. For quiescence and proliferation
analyses, 3 3 104 cells were plated on eight-well glass cham-
berslides (Nunc, Thermo Scientific, MA, www.thermoscientific.
com) precoated with 0.01% poly-L-ornithine (Sigma-Aldrich,
MO, www.sigmaaldrich.com) overnight followed by 10 mg/ml
laminin (Sigma-Aldrich) for 1 hour at 37C.
pcDNA3.1 empty vector control plasmid and
pcDNA::hChd7 plasmid constructs (kindly provided by Dr. J.
Wysocka) [36], and pCLIG empty vector control plasmid and
pCLIG::rHes5 plasmid constructs (kind gifts from Dr. R
Kageyama) [37], were transfected into fetal-derived NSCs
using Amaxa nucleofection (Amaxa Biosystems, Switzerland,
www.lonza.com/research/). Briefly, 10 mg of plasmid was
transfected into 8 3 106 NSCs using the Primary Neuron
Nucleofector kit and program A-033, according to manufac-
turer’s recommendations. For experiments involving
pcDNA::hChd7 constructs, 24 hours after nucleofection, one
sample of cells were trypsinized and taken into Trizol for RNA
isolation. A second sample was transferred to quiescence con-
ditions for 4 days before RNA was extracted. For experiments
involving pCLIG::rHes5 constructs, cells were put into quies-
cence conditions 24 hours after nucleofection and analyzed
24 hours later.
For FACS isolation, NSCs from the hippocampus of four
adult GLAST::CreERT2;RYFP/1 and GLAST::CreERT2;Chd7f/f;RYFP/
1 mice were dissociated as described previously [38]. Live
(DAPI-negative), YFP-negative, and YFP-positive cells were
sorted directly into Trizol (Life Technologies; www.lifetechnolo-
gies.com) using a FACS Aria II (BD Biosciences, U.K., www.
bdbiosciences.com).
Western Blot
Total cell lysates were prepared by lysing 1 3 106 cells in
100 ml 8 M urea, 1% CHAPS, 50 mM TRIS pH7.9 followed by
the removal of DNA by centrifugation. Proteins (20 mg per
lane) were resolved on a 3–7% Tris-acetate gel (Life Technolo-
gies) and transferred to a nitrocellulose membrane (Life Tech-
nologies). After blocking with 0.5% nonfat milk powder in TBS
with 0.5% Tween 20 (TBST), the membrane was incubated
with primary antibodies (aCHD7, Abcam, U.K., www.abcam.
com, ab31824, 1/2000; aCPSF100, Bethyl, TX, www.bethyl.
com, A301–581A, 1/1000) in 5% BSA, TBST overnight at 4C.
After washing and incubation with horse radish peroxidase
(HRP)-conjugated secondary antibody (Millipore, U.K., www.
emdmillipore.com) for 1 hour at room temperature, HRP con-
jugates were detected using Clarity Western ECL reagent (Bio-
rad, U.K., www.bio-rad.com). Gels were visualized on a Bio-
Rad gel doc system and images prepared using Adobe
Photoshop.
RNA Isolation and Quantitative RT-PCR Analysis
RNA extraction from approximately 1 3 106 fetal-derived
NSCs, a minimum of 1 3 103 FACS-isolated cells, and the
microdissected DG of 2–3 animals per condition was per-
formed with Trizol (Life Technologies) according to the manu-
facturer’s suggested modifications, by the addition of
ultrapure glycogen (Life Technologies). First-strand comple-
mentary DNA was synthesized from 200 ng of RNA using the
Precision Nanoscript Reverse Transcriptase kit (PrimerDesign
Ltd., U.K., www.primerdesign.co.uk) according to manufac-
turer’s recommendations. Real-time quantitative polymerase
chain reaction (RT-qPCR) was performed on a Stratagene
Mx3000p Real Time PCR machine (Agilent Technologies, CA,
www.home.agilent.com), with Precision 23 RT-PCR MasterMix
(PrimerDesign Ltd.) using primers against Chd7, hChd7 (which
may recognize mouse Chd7), Hes5, rHes5 (which may recog-
nize mouse Hes5), Pax6 (Designed by PrimerDesign Ltd.),
Ccnb1, Ccnd1, Ccnd2, Ccne1, Cdk1, Cdk2, Btg1, Mtor, Nestin,
and Gapdh as a normalizing control to give DDCq values rela-
tive to wild-type samples. Primer sequences are shown in
Supporting Information Table 1.
Forebrain Processing
Adult mice were given a lethal dose of Euthanal (pentobaribi-
tal sodium, Merial, U.K., www.merial.co.uk) and perfused with
ice-cold PBS followed by ice-cold 4% PFA. Brains were dis-
sected and further fixed in 4% PFA overnight at 4C. For
immunohistochemistry, fixed brains were cryoprotected in
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15% sucrose and 7.5% gelatine and frozen in methylbutane
(Sigma-Aldrich) in dry ice.
Immunohistochemistry and Immunocytochemistry
Coronal brain sections (20-mm-thick) were prepared using a
Cryotome (Bright Instrument Co Ltd., U.K., www.brightinstru-
ments.com) on Superfrost1 slides. Slides were incubated in
PBS at 37C for 40 minutes to remove gelatine and then post-
fixed in 4% PFA for 10 minutes. For 5-bromodeoxyuridine
(BrdU), CHD7, MCM2, and S100b detection, antigen-retrieval
was performed by incubating slides with 2N HCl for 17 minutes
at 37C. Acid was neutralized by incubating slides in 0.1 M
borate buffer, pH 8.5. Sections were permeabilized by washes
with 0.1% Triton X (Sigma) in PBS (PBSTx). Sections were
blocked in 10% heat-inactivated goat serum (GS) for 1 hour
before incubation with primary antibody diluted in 5% GS in
PBSTx overnight at 4C. The antibodies used were as follows:
rat anti-BrdU (1/50, Abcam), mouse anti-Ki67 (1/50, Abcam),
mouse anti-SOX2 (1/800, Abcam), rabbit anti-CHD7 (1/80,
Abcam), rabbit anti-glial fibrillary acidic protein (GFAP) (1/500,
Sigma), chicken anti-YFP (1/200, Abcam), rabbit anti-S100b
(1/100, Abcam) rabbit anti-cleaved caspase-3 (1/200, Cell Sig-
naling) mouse anti-GFAP (1/1000, Abcam), mouse anti-BM28
(MCM2; 1/400, BD Biosciences), mouse anti-ASCL1 (1/200, BD
Biosciences), rabbit anti-DCX (1/500, Abcam), mouse anti-NeuN
(1/100, Chemicon, CA, www.chemicon.com). Sections were
incubated with Alexa-Fluor-labeled secondary antibodies diluted
at 1/200 (Life Technologies) and DAPI at 1/5000 in 5% GS in
PBSTx for 1 hour before mounting on to coverslips with Citi-
fluor (Citifluor Ltd., U.K., www.citifluor.com). For double immu-
nofluorescence of CHD7 with GFAP, sections were degelatinized
and permeabilized as above, and blocked for 1 hour in blocking
buffer containing 0.1 M Tris-HCl pH7.5, 0.15 M NaCl, and 0.5%
blocking reagent (Perkin Elmer, U.K., www.perkinelmer.co.uk).
Incubation with primary antibody against CHD7 (Abcam) for 1
hour at room temperature at 1/700 in TNT buffer (0.1 M Tris-
HCl, 0.15 M NaCl, and 0.05% Tween), was followed by washes
and incubation with goat anti-rabbit biotin (Abcam) at 1/300 in
TNT for 1 hour, anti-GFAP (DAKO) 1/200 in TNT for 1 hour,
goat anti-rabbit-488 (Abcam) 1/350 in TNT for 1 hour for detec-
tion of anti-GFAP, ABC reagent (Vector Laboratories Ltd., U.K.,
www.vectorlabs.co.uk) for 30 minutes at room temperature,
and finally, Cyanine 5 Tyramide signal amplification reagent
(Perkin Elmer, MA, http://www.perkinelmer.com) for 10 minutes
to amplify the CHD7 signal, with adequate washes in TNT
between all steps. Slides were mounted in Vectashield contain-
ing DAPI (Vector Laboratories Ltd).
Cells on chamber slides were fixed with 4% PFA for 10
minutes before premeabilization in PBSTx and blocking in 10%
GS in PBSTx for 1 hour. Immunostaining was then performed
as above.
Fluorescent images were captured on a confocal laser-
scanning microscope (Leica SP5, Germany, www.leica.co.uk)
using a 633 glycerol-immersion objective, or an 80i com-
pound microscope (Nikon Ltd., U.K., www.nikon.co.uk). Images
were processed using NIS Elements Viewer 4.0 or LAS AF Lite
and Adobe Photoshop CS5 software.
Analysis of NSCs and Their Progeny
For the analysis of cells expressing CHD7, a minimum of 100
CHD71 cells were analyzed across 24 hippocampal sections at
least 60 mm apart from three wild type mice by a max projec-
tion of a 20-mm Z-stack in 0.5 mm steps on a confocal laser-
scanning microscope. For the quantification of the number of
CHD71, DCX1, BrdU1, GFP1, NeuN1, S100b1, cleaved cas-
pase-31, SOX21, or GFAP1 cells a minimum of 52 DG sections
at least 60 mm apart were quantified across a minimum of
three animals per condition. For the analysis of the number
of proliferating NSCs, a minimum of 200 BrdU1 cells were
analyzed by confocal microscopy from at least 60 DG sections
across at least four animals per condition. For the analysis of
in vitro proliferating cells, automated particle analysis with
ImageJ software (National Institute of Health, http://rsbweb.
nih.gov/ij/) was performed on a minimum of 4000 cells per
culture condition. All counts were performed blind.
In Vivo Activation of Cre Recombinase and Cell
Division Analysis
Adult mice were given one intraperitoneal (I.P.) injection of
80 mg/kg (typically 120 ml of 20 mg/ml) TAM (Sigma-Aldrich)
diluted in corn oil (Sigma-Aldrich) daily for 5 days. To analyze
SGZ cell proliferation, animals were given one I.P. injection of
BrdU (Sigma-Aldrich) dissolved in isotonic saline (0.9% NaCl)
at a concentration of 75 mg/kg, 24 hours before sacrifice
[39].
Statistical Analysis
All data are represented as mean6 SEM; *, p< 0.05;
**, p< 0.01; ***, p< 0.001, Student’s t-test.
RESULTS
CHD7 Is Expressed in Hippocampal NSCs
To determine whether CHD7 is present in NSCs in the adult
hippocampus, cryosections were immunostained with antibod-
ies to CHD7, GFAP (to identify radial NSCs) and ASCL1
(achaete-scute complex homolog 1, to identify neuronal pro-
genitors) [40–42]. The majority of CHD71 cells were ASCL11
(Fig. 1A, 1B). Importantly, a small, but significant fraction (8%)
of CHD71 cells were GFAP1 radial NSCs in the SGZ (Fig. 1C,
1D), implying a role for CHD7 in hippocampal NSCs. An analy-
sis of CHD7 expression in different cellular subsets confirmed
that 95% of ASCL11 cells expressed CHD7 (Fig. 1E). Taken
together with data from Feng et al. who showed that the
majority of CHD7 is present in rapidly dividing cells [26], it
appears that CHD7 expression might be upregulated in type 1
NSCs as they exit the quiescent state and that high CHD7
expression marks most progenitors as they progress through a
highly proliferative type 2 ASCL11 transient amplifying state
towards neurons (Fig. 1G). Interestingly, a careful analysis of
GFAP1 radial NSCs in the SGZ indicated that 35% of type 1
cells were positive for CHD7 (Fig. 1F). As only a small fraction
(1–4%) of these cells actively divide (see Fig. 6D, 6E; [19]),
these observations indicate that CHD7 is expressed in a pro-
portion of NSCs that would include quiescent and activated
subsets (Fig. 1G).
Deletion of Chd7 in NSCs
To investigate the function of CHD7 in the adult hippocampus,
we utilized the GLAST::CreERT2 mouse line to delete Chd7 in
NSCs in the adult brain [28]. We first determined the
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recombination efficiency in the DG by crossing the GLAST::
CreERT2 line to a RYFP reporter line to generate GLAST::
CreERT2;RYFP/1 mice. Adult GLAST::CreERT2;RYFP/1 mice
were analyzed 7 and 28 days after tamoxifen (TAM) injection
(Fig. 2A). Seven days after TAM administration, 78–91% of
radial GFAP1 cells were YFP1, showing efficient recombination
in NSCs (Fig. 2B, 2C). Twenty-eight days after the last tamoxi-
fen injection, YFP1 cells in the granular layer of the DG were
visible, representing newborn neurons derived from Cre-
recombined NSCs (Fig. 2D). Furthermore, at this time point
86–94% of radial GFAP1 cells were still YFP1 (Fig. 2B, 2D),
indicating that quiescent NSCs that have undergone Cre
Figure 1. Chromodomain–helicase-DNA-binding protein 7 (CHD7) is expressed in hippocampal neural stem cells and progenitors. (A):
Coronal adult mouse dentate gyrus (DG) section showing the subgranular zone (SGZ) immunostained with anti-CHD7 and anti-ASCL1
antibodies and DAPI. Scale bar5 20 mm. (B): Quantification of the percentage of CHD71 cells that express ASCL1. (C): Coronal adult
mouse DG section showing the SGZ immunostained with anti-CHD7 and anti-glial fibrillary acidic protein (GFAP) antibodies and DAPI.
White arrow heads show SGZ CHD71 cells with a radial GFAP process. Scale bar5 20 mm. (D): Quantification of the percentage of
CHD71 cells that also display a radial GFAP1 process. (E, F): Quantification of the percentage of ASCL11 (E) and radial GFAP1 cells (F)
that express CHD7. n5 100–150 cells from 2 to 3 animals. (G): Schematic illustration of CHD7 expression in the adult hippocampal neu-
rogenic niche. Abbreviations: ASCL1, achaete-scute complex homolog 1; CHD7, chromodomain–helicase-DNA-binding protein 7; DAPI, 40,6-
diamidino-2-phenylindole; DCX, doublecortin; GFAP, glial fibrillary acidic protein; MCM2, minichromosome maintenance deficient 2 mitotin.
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Figure 2. Deletion of Chd7 from GLAST and Nestin-expressing progenitors. (A): Schematic of the experimental strategy to induce
recombination and YFP expression in subgranular zone (SGZ) neural stem/progenitor cells (NSCs). Adult GLAST::CreERT2;RYFP/1 mice
were given one injection of 80 mg/kg tamoxifen (TAM) a day for 5 days and analyzed either 7 days or 28 days after TAM injection. (B):
Quantification of the percentage of radial GFAP1 cells that were GFP1 in the SGZ 7 days (7d) and 28 days (28d) after TAM injection. At
least 90 GFAP1 cells were counted. n5 2 animals. (C, D): Representative image of a coronal section of the dentate gyrus of GLAST::-
CreERT2;RYFP/1 mice 7 days (C) or 28 days (D) after TAM injection stained with antibodies against green fluorescent protein (GFP) and
glial fibrillary acidic protein (GFAP). GFP antibodies recognize YFP protein. White arrow heads show GFAP1GFP1 astrocytic processes. Yel-
low arrow head shows a GFAP-GFP1 cell in the granular layer in (D). Note the significant overlap between GFAP and GFP. (E, F): Repre-
sentative image of a section of the SGZ stained with antibodies raised against CHD7 and ASCL1 in control (E) and Chd7null (F) adult
brains 4 weeks after TAM administration. Sections were stained with antibodies against ASCL1 to identify the NSC population that
normally express high levels of CHD7. (G, H): Quantification of the number of CHD71 cells in the SGZ of control (Ctrl) and Chd7null
mice 1 week (G) and 4 weeks (H) after TAM injection. n5 2–4 animals per condition. (I, J): RT-qPCR quantification of Pax6 expression in
YFP- and YFP1 live (DAPI-negative) cells FACS-isolated from microdissected dentate gyrus (DG) of GLAST::CreERT2;RYFP/1 (control; Ctrl; I)
and GLAST::CreERT2;Chd7f/f;RYFP/1 (Chd7null; J) mice 7 days after TAM injection. A minimum of 1000 cells from 4 animals per condition
were isolated. (K): RT-qPCR quantification of Chd7 expression in FACS-isolated YFP1 control and Chd7null NSCs. Data from (I–K) are
from four reactions. All data represented as mean6 SEM. Abbreviations: ASCL1, achaete-scute complex homolog 1; CHD7,
chromodomain–helicase-DNA-binding protein 7; DAPI, 40,6-diamidino-2-phenylindole; GFAP, glial fibrillary acidic protein; GFP, green fluo-
rescent protein; RFYP, Rosa-EYFP; TAM, tamoxifen; YFP, yellow fluorescent protein.
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recombination are maintained in the niche. Importantly, no
YFP1 cells were observed in mice not injected with TAM, indi-
cating no leaky Cre or YFP expression (data not shown).
Therefore, the GLAST::CreERT2 line allows for efficient recom-
bination in hippocampal NSCs.
To delete Chd7 specifically from adult NSCs, GLAST::-
CreERT2;Chd7f/f mice were generated. To test the efficiency of
Chd7 deletion, sections from the DG of GLAST::CreERT2;Chd7f/f
(Chd7null) and Cre-negative control mice (control) were
stained with antibodies against CHD7 (Fig. 2E, 2F). Fewer than
3% of the number of CHD7-positive cells present in controls
was detected in the DG of Chd7null mice, indicating highly
efficient deletion of Chd7 in vivo (Fig. 2G, 2H).
To further confirm the expression and efficient deletion of
CHD7 in adult NSCs, GLAST::CreERT2;RYFP/1 (control) and
GLAST::CreERT2;Chd7f/f;RYFP/1 (Chd7null) mice were injected
with TAM and brains were collected 7 days after the last
injection. Live (DAPI-negative), YFP-positive, and YFP-negative
cells were FACS-isolated from the hippocampus and RNA was
extracted. YFP1 cells from both control and Chd7null mice
expressed high levels of the NSC markers Pax6 [42], Nestin,
and Hes5 [43] compared with YFP- cells (Fig. 2I, 2J). Corre-
spondingly, Chd7 expression was markedly reduced in YFP1
sorted cells from Chd7null mice (Fig. 2K). Collectively, these
data demonstrate that CHD7 is expressed by adult hippocam-
pal NSCs and that CHD7 can be ablated effectively in these
cells in the adult hippocampus.
CHD7 Is Required for Neural Stem Cell Quiescence
Previous work has shown that the deletion of CHD7 from hip-
pocampal NSCs resulted in defects in neuronal differentiation
[26]. This study did not examine the effects of Chd7 deletion
on the quiescent NSC population. To determine whether Chd7
deletion affected NSC characteristics, GLAST::CreERT2;Chd7f/f
and Cre-negative control mice were injected with TAM and
examined 7 days later (Fig. 3A). DG sections were immuno-
stained for SOX2 and GFAP to identify stem (SOX21GFAP1
SGZ cells with a radial morphology) and progenitor cells
(SOX21GFAP- SGZ cells) [16], ASCL1 to mark a subset of stem/
progenitor cells and DCX to visualize immature neurons. The
numbers of stem and progenitor cells and DCX1 immature
neurons were not altered 7 days after TAM injection (Fig. 3B–
3E), indicating that the cellular composition of the DG
remained the same at this time-point.
We next asked whether cell proliferation was affected by
Chd7 depletion. Six days after TAM administration, BrdU was
injected and brains were collected 24 hours later (Fig. 3A).
We observed over a twofold increase in the number of cells
that had passed through S-phase during the final 24 hours of
the experiment (BrdU1) in the SGZ of Chd7null mice com-
pared with controls (Fig. 3F, 3G). To identify the cell type
responsible for the increased proliferation in the SGZ, sections
were immunostained with antibodies against BrdU, SOX2, and
GFAP to distinguish NSCs (GFAP1SOX21 SGZ cells with a radial
morphology) from progenitors (GFAP-SOX21 SGZ cells) [16].
The number of BrdU1 radial NSCs was over 2.5-fold greater
in Chd7null mice compared with controls (Fig. 3H). Interest-
ingly, the number of progenitors that had cycled was the
same between Chd7null and control mice (Fig. 3I), suggesting
that Chd7 primarily regulates NSC and not progenitor prolifer-
ation. Indeed, the number of proliferating NSCs
(GFAP1MCM21 SGZ cells with a radial morphology) was
increased over twofold in Chd7null mice compared with con-
trols (Fig. 3J, 3L), whereas the number of proliferating progen-
itors (GFAP-MCM21 SGZ cells) was not altered (Fig. 3K).
To examine whether the increase in NSC number was
caused by an increase in symmetric NSC divisions, we
searched for the presence of two or more BrdU1 radial NSCs
within close proximity to one another at 1, 4, and 12 weeks
after Chd7 deletion. We could not detect two BrdU1 NSCs
within close proximity to one another at any of these time
points (data not shown). These results suggest that there is
no dramatic shift in NSC divisions to favor symmetric cell divi-
sions in Chd7null cells. However, a more extensive and sophis-
ticated analysis may be required to accurately compare the
propensity of Chd7null and control NSCs to undergo symmet-
ric versus asymmetric cell divisions.
To find further evidence in support of a role for CHD7 in
NSC quiescence, we used a recently described in vitro model
of reversible NSC quiescence [33–35]. Fetal NSCs obtained
from the cortex and striatum of E16.5 Nestin-Cre;Chd7f/f
(Chd7null) and Cre-negative embryos (control) were isolated
and cultured in media containing the mitogens FGF2 and EGF
[44]. These cells retain multilineage differentiation capacity
after prolonged expansion [31] and give a high yield of neu-
rons when cultured under certain conditions [32]. Upon
removal of EGF and addition of BMP4 to the culture media,
NSCs become quiescent. This quiescent state is fully reversible
upon BMP4 withdrawal and EGF addition [33, 35]. We con-
firmed that Chd7 was expressed at high levels in control NSCs
under growth conditions (Fig. 3M). Chd7 transcripts were
downregulated by approximately 68% under quiescent condi-
tions, consistent with previous studies [26]. No Chd7 tran-
scripts (Fig. 3M) or CHD7 protein could be detected in
Chd7null cells (Fig. 3N). Control NSCs stopped proliferating
and entered a quiescent state within 72 hours of transfer into
quiescent culture conditions (Fig. 3O). By contrast, >10% of
Chd7null NSCs were refractory to quiescent induction and
remained in a proliferative state even after 96 hours of cul-
ture with BMP4 (Fig. 3O, Quiescence media). Chd7null cells
retained the capacity to fully reactivate to a proliferative state
(Fig. 3O, Growth media). These in vitro findings further sup-
port our identification of CHD7 as a regulator of NSC
quiescence.
Loss of Chd7 Causes a Transient Increase in Immature
Neuron Production
Loss of NSC quiescence has been shown in some instances to
lead to a transient increase in neurogenesis caused by
increased conversion of stem cells to lineage restricted pro-
genitors [15]. To test whether a loss of NSC quiescence in
Chd7null mice was associated with increased neurogenesis
shortly after Chd7 deletion, GLAST::CreERT2;Chd7f/f (Chd7null)
and Cre-negative control mice were examined 4 weeks after
TAM injection and sections of the DG were stained with anti-
bodies against GFAP and SOX2 to mark NSCs and progenitors
and DCX to label immature neurons. Chd7null mice exhibited
no significant change in the number of NSCs (Fig. 4A), and a
small increase in the number of GFAP-SOX21 progenitors
(Fig. 4B) and immature neurons in the DG compared to con-
trols (Fig. 4C, 4D), showing that a loss of Chd7 in NSCs results
in an increase in immature neuron formation. To further show
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Figure 3. Chromodomain–helicase-DNA-binding protein 7 (CHD7) regulates neural stem/progenitor cell (NSC) quiescence. (A): Sche-
matic diagram of the experimental strategy to delete Chd7 from adult NSCs. Six days after tamoxifen (TAM) administration 5-
bromodeoxyuridine (BrdU) was injected and brains collected 24 hours later. (B–D): Quantification of the number of radial GFAP1SOX21
NSCs (B), GFAP-SOX21 progenitor cells, and ASCL11 stem/progenitor cells (D) in the subgranular zone (SGZ) of Chd7null and control
(Ctrl) mice 1 week after TAM injection. (E): Quantification of the number of DCX1 cells in the dentate gyrus (DG) of Chd7null and con-
trol (Ctrl) mice 1 week after TAM injection. (F): Representative image of a section of the DG stained with antibodies against BrdU,
SOX2, and glial fibrillary acidic protein (GFAP) with DAPI. Yellow arrow head shows a BrdU1 NSC (BrdU1SOX21GFAP1 cell in the SGZ),
pink arrow head shows a BrdU- NSC, light blue arrow heads show a BrdU1 progenitor (BrdU1SOX21GFAP-). Scale bar5 20 mm. (G):
Quantification of the total number of BrdU1 cells in the SGZ of Chd7null and ctrl mice. (H, I): Quantification of the number of BrdU1
NSCs (H) and progenitors (I) in the SGZ of Chd7null and ctrl mice. (J, K) Quantification of the number of proliferating (MCM21) radial
GFAP1 SGZ NSCs (J) and MCM21 GFAP- proliferating cells in the SGZ of Chd7null and ctrl mice (K). For all experiments, n5 3–4 animals
per condition. (L): Representative image of a section of the DG stained with antibodies against MCM2, GFAP and DAPI. White arrow
head shows a GFAP1MCM21 NSC, blue arrow head shows a GFAP1MCM2- quiescent NSC. Scale bar5 20 mm. (M) RT-qPCR quantifica-
tion of Chd7 expression in cultured fetal-derived NSCs from Nestin-Cre;Chd7f/f (Chd7null) and Cre-negative (control; Ctrl) embryos under
growth conditions (Growth) and after incubation with media containing 50 ng/ml BMP4 (quiescence), relative to ctrl. Note Chd7 expres-
sion is completely absent from Chd7null cells. n5 4 cultures. (N): Western blot for CHD7 on total cell lysates of cultured fetal-derived
NSCs from Chd7null (NestinCre;Chd7-/-) and control (Chd71/1) cells. Cleavage and polyadenylation specificity factor 100 (CPSF100) was
used as a loading control. (O): Quantification of the percentage of proliferating (Ki671) control and Chd7null cells in vitro under growth
conditions and after incubation with media containing 50 ng/ml BMP4 (quiescence). Note that Chd7null cells are refractory to quies-
cence induction after 72 and 96 hours in quiescence media. Both Chd7null and ctrl cells are able to return to a proliferative state when
returned to growth conditions (growth media). n5 4 cultures. All data represented as mean6 SEM; *, p< 0.05; ***, p< 0.001
Student’s t-test. Abbreviations: BrdU, 5-bromodeoxyuridine; CHD7, chromodomain–helicase-DNA-binding protein 7; CPSF100, cleavage
and polyadenylation specific factor 2, 100 kDa subunit; DAPI, 40,6-diamidino-2-phenylindole; GFAP, glial fibrillary acidic protein; MCM2,
minichromosome maintenance deficient 2 mitotin; NSC, neural stem/progenitor cell; SGZ, subgranular zone; TAM, tamoxifen.
that loss of Chd7 and loss of NSC quiescence causes a tran-
sient increase in immature neuron production, GLAST::-
CreERT2;Chd7f/f;RYFP/1 (Chd7null) and GLAST::CreERT2; RYFP/
1 (control) mice were examined 4 weeks after TAM injection.
Sections of the DG were stained with antibodies raised
against green fluorescent protein (GFP) and DCX to label
newly generated immature neurons (Fig. 4E). This analysis
confirmed that immature neuron production is increased in
Chd7null mice compared to controls (Fig. 4F). However, the
number of GFP1NeuN1 newly produced neurons was
decreased in Chd7null mice compared with controls (Fig. 4G,
4H), consistent with a previous study showing that CHD7 is
required for NSC differentiation [26]. Taken together, our data
are consistent with two roles for CHD7: 1) in maintaining NSC
quiescence (as reported in the present manuscript) and 2)
neuronal maturation (as shown here and reported by Feng
et al. [26]).
CHD7 Regulates Hippocampal Neurogenesis
We have shown that loss of Chd7 causes a loss of NSC quies-
cence followed by a transient increase in progenitor number
and immature neuron production soon after deletion. To
determine the longer-term effect of Chd7 deletion on neuro-
genesis, adult GLAST::CreERT2;Chd7f/f (Chd7null) and Cre-
negative control mice (control) mice were examined 12 weeks
after TAM injection. In agreement with Feng et al., Chd7null
mice exhibited a significant decrease in the number of
GFAP-SOX21 progenitors (Fig. 5A) and immature (DCX1)
Figure 4. Loss of Chd7 and neural stem/progenitor cell (NSC) quiescence results in an increase in immature neuron production. (A, B):
Quantification of the number of radial GFAP1SOX21 NSCs (A) and GFAP-SOX21 progenitor cells in the subgranular zone (SGZ) (B) of
GLAST::CreERT2;Chd7f/f (Chd7null) and Cre-negative control (Ctrl) mice 4 weeks after tamoxifen (TAM). (C): Representative image of a
section of the dentate gyrus (DG) of GLAST::CreERT2;Chd7f/f (Chd7null) and Cre-negative control (Ctrl) mice 4 weeks after TAM injection
stained with antibodies against DCX. Scale bar5 100 mm. (D): Quantification of the number of DCX1 cells in the DG of Chd7null and
ctrl mice 4 weeks after TAM injection. (E): Representative image of a section of the DG of GLAST::CreERT2;Chd7f/f;RYFP/1 mice 4 weeks
after TAM injection stained with antibodies against green fluorescent protein (GFP) and DCX. White arrow heads show GFP1DCX1 cells.
Scale bar5 50 mm. (F): Quantification of the number of YFP1DCX1 newly generated immature neurons in the DG of GLAST::CreERT2;
RYFP/1 (control; Ctrl) and GLAST::CreERT2;Chd7f/f;RYFP/1 (Chd7null) mice 4 weeks after TAM injection. (G): Representative image of a
section of the DG of GLAST::CreERT;RYFP/1 mice 4 weeks after TAM injection stained with antibodies against GFP and NeuN. White
arrow heads show GFP1NeuN1 cells. Scale bar5 50 mm. (H): Quantification of the number of YFP1NeuN1 new mature neurons in the
DG of GLAST::CreERT2;RYFP/1 (control; Ctrl) and GLAST::CreERT2;Chd7f/f;RYFP/1 (Chd7null) mice 4 weeks after TAM injection. n5 4 ani-
mals per condition. All data represented as mean6 SEM; *, p< 0.05; **, p< 0.01; ***, p< 0.001 Student’s t-test. Abbreviations: DAPI,
40,6-diamidino-2-phenylindole; DCX, doublecortin; GFP, green fluorescent protein; NSC, neural stem/progenitor cells.
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neurons (Fig. 5B, 5C) [26]. Furthermore, staining adult hippo-
campal sections of GLAST::CreERT2;RYFP/1 (control) and
GLAST::CreERT2;Chd7f/f;RYFP/1 (Chd7null) mice 12 weeks after
TAM injection with antibodies to GFP and NeuN showed an
impaired ability of Chd7null mice to generate new granule
neurons (Fig. 5D). To determine the cause of the reduction in
progenitor and immature neuron number in Chd7null mice 12
weeks after deletion, we stained hippocampal sections of
adult GLAST::CreERT2;RYFP/1 (control) and GLAST::
CreERT2;Chd7f/f;RYFP/1 (Chd7null) 4 and 12 weeks after TAM
injection with antibodies to GFP and cleaved caspase-3
(aCasp3), a marker of apoptosis. Chd7null mice displayed an
increased number of apoptotic cells. Based on morphology,
apoptosis was present in the population of newly generated
GFP1 progenitor (type 2 and 3) cells, and not in NSCs with
radial morphology (Fig. 5E–5G). These data confirm that Chd7
is required for normal levels of neurogenesis and the survival
of newborn neural progenitors in the adult DG. Collectively,
our data suggest a model whereby the loss of NSC quiescence
results in the premature conversion of stem cells into progen-
itors, which fail to fully mature and are eliminated by
apoptosis.
Deletion of Chd7 and Loss of NSC Quiescence Results
in the Depletion of the NSC Pool
Adult stem cell quiescence is essential for the preservation of
a functional stem cell pool throughout life [10, 13, 15]. To
determine whether Chd7 deletion affected hippocampal stem
cell number, adult GLAST::CreERT2;Chd7f/f (Chd7null) and Cre-
negative control mice were examined 12 weeks after TAM
injection (Fig. 6A). DG sections were stained with antibodies
against the stem cell markers GFAP and SOX2 and the number
of GFAP1SOX21 radial SGZ NSCs were counted (Fig. 6B). Inter-
estingly, at this time point, Chd7null mice displayed an
increase in the number of SGZ NSCs (Fig. 6C). To determine if
NSCs were more proliferative in Chd7null mice, Chd7null and
control mice were injected with BrdU 24 hours before exami-
nation, 12 weeks after TAM injection. The number of BrdU1
radial NSCs was almost threefold greater in Chd7null mice
compared to controls (Fig. 6D) and the number of MCM21
Figure 5. Loss of Chd7 results in a decrease in neurogenesis and apoptosis of newly generated cells. (A): Quantification of the number
of GFAP-SOX21 subgranular zone (SGZ) progenitor cells in the dentate gyrus (DG) of GLAST::CreERT2;Chd7f/f (Chd7null) and Cre-negative
control (Ctrl) mice 12 weeks after tamoxifen (TAM). (B): Representative image of a section of the DG of Chd7null and control (Ctrl) mice
12 weeks after TAM injection stained with antibodies against DCX. Scale bar5 100 mm (C): Quantification of the number of DCX1 cells
in the DG of Chd7null and ctrl mice 12 weeks after TAM injection. n5 4 animals / condition. (D): Quantification of the number of
YFP1NeuN1 cells in the DG of GLAST::CreERT2;RYFP/1 (control; Ctrl) and GLAST::CreERT2;Chd7f/f;RYFP/1 (Chd7null) mice 12 weeks after
TAM injection (E): Representative image of a section of the DG of GLAST::CreERT2;Chd7f/f;RYFP/1 mice 4 weeks after TAM injection
stained with antibodies against green fluorescent protein (GFP) (YFP) and cleaved caspase-3 (aCaps3) showing an apoptotic non-neural
stem/progenitor cells (NSC) (nonradial) cell. Scale bar5 10 mm. (F, G): Quantification of the number of YFP1aCasp31 (apoptotic) newly
generated cells in GLAST::CreERT2;RYFP/1 (Ctrl) and GLAST::CreERT2;Chd7f/f;RYFP/1 (Chd7null) mice 4 weeks (F) and 12 weeks (G) after
TAM injection. All data represented as mean6 SEM; *, p< 0.05; **, p< 0.001; ***, p< 0.001 Student’s t-test. Abbreviations: DAPI, 40,6-
diamidino-2-phenylindole; DCX, doublecortin; NSC, neural stem/progenitor cells; YFP, yellow fluorescent protein.
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Figure 6. Deletion of Chd7 from adult NSCs results in the depletion of the stem cell pool. (A): Schematic diagram of the experimental
strategy to delete Chd7 from adult NSCs for 12 weeks. (B): Representative image of a section of the dentate gyrus (DG) of GLAST::
CreERT2;Chd7f/f mice treated with tamoxifen (TAM) (Chd7null) and Cre-negative controls (Ctrl) stained with antibodies against glial fibril-
lary acidic protein (GFAP) and SOX2 with DAPI 12 weeks after Chd7 deletion. Scale bar5 10 mm (C): Quantification of the number of
GFAP1SOX21 radial NSCs in the subgranular zone (SGZ) of ctrl and Chd7null mice 12 weeks after TAM. (D, E): Quantification of the
number of BrdU1 NSCs (BrdU1SOX21GFAP1; D) and MCM21GFAP1 radial NSCs (E) in the SGZ of Chd7null and ctrl mice. (F): Schematic
diagram of the experimental strategy to delete Chd7 from adult NSCs for 8 months. (G): Representative image of a section of the DG of
Cre-negative controls and GLAST::CreERT2;Chd7f/f mice treated with TAM (Chd7null) and stained with antibodies against GFAP and SOX2
with DAPI 8 months after Chd7 deletion. Note a reduction in radial GFAP processes through the granular layer and a reduction in
SOX21 cells in the SGZ in Chd7null sections. Boxed areas, enlarged in the ‘Enlarge’ panel, show radial GFAP1SOX21 NSCs (light blue
arrowheads) and GFAP-SOX21 progenitors (white arrowheads). (H, I): Quantification of the number of GFAP1SOX21 radial NSCs (H) and
GFAP-SOX21 progenitors (I) in the SGZ of ctrl and Chd7null mice 8 months after TAM administration. (J): Quantification of the number
of DCX1 immature neurons in the DG of ctrl and Chd7null mice 8 months after TAM injection. (K, L): Quantification of the number of
BrdU1 NSCs (BrdU1SOX21GFAP1; K) and MCM21GFAP1 radial NSCs (L) in the SGZ of Chd7null and ctrl mice 8 months after TAM injec-
tion. (M, N): Quantification of the number of SGZ YFP1GFAP1 radial NSCs that are apoptotic (aCasp31) in the DG of GLAST::CreERT2;
RYFP/1 (Ctrl) and GLAST::CreERT2;Chd7f/f;RYFP/1 (Chd7null) mice 4 weeks (M) and 12 weeks (N) after TAM injection. Note the very low
numbers of apoptotic NSCs at both time points. (O): Quantification of the number of apoptotic (aCasp31) radial GFAP1 NSCs in the SGZ
of Cre-negative controls and GLAST::CreERT2;Chd7f/f mice 8 months after TAM injection. Note the low number of apoptotic NSCs. (P, Q):
Quantification of the number of S100b1 mature astrocytes in the granular layer, SGZ and hilus of Cre-negative controls and GLAST::
CreERT2;Chd7f/f mice 12 weeks (P) and 8 months (Q) after TAM injection. For all experiments, n5 3–4 animals per condition. All data
represented as mean6 SEM; *, p< 0.05; **, p< 0.01; ***, p< 0.001 Student’s t test. Abbreviations: BrdU, 5-bromodeoxyuridine; CHD7,
chromodomain–helicase-DNA-binding protein 7; DCX, doublecortin; GFAP, glial fibrillary acidic protein; NSC, neural stem/progenitor cells;
TAM, tamoxifen; YFP, yellow fluorescent protein.
proliferating radial NSCs was over twofold greater (Fig. 6E),
consistent with the increased proliferation of this population
observed at earlier time points (Fig. 3H, 3J).
Sustained NSC proliferation has been shown in other stud-
ies to be associated with the premature depletion of the
stem cell pool [13, 19]. To determine whether Chd7 deletion
has a similar effect, Chd7null and control mice were examined
8 months after TAM injection (Fig. 6F). Indeed, Chd7null mice
displayed a significant depletion of NSCs, and a reduction in
progenitor cell numbers and immature neurons (Fig. 6G–6J).
Furthermore, the remaining NSCs in Chd7null mice were more
proliferative than in controls (Fig. 6K, 6L) suggesting that NSC
depletion is likely to continue during further ageing. Taken
together, our data are consistent with other studies in which
loss of NSC quiescence is linked to NSC depletion [13, 19]. To
determine if the loss of Chd7 and NSC quiescence led to
increased apoptosis of NSCs, hippocampal sections of adult
GLAST::CreERT2;RYFP/1 (control) and GLAST::CreERT2;Chd7f/f;
RYFP/1 (Chd7null) were stained with antibodies against GFP
and cleaved caspase-3 and the number of apoptotic radial
YFP1 NSCs were counted at 4 weeks and 12 weeks after TAM
injection. Apoptotic NSCs were very rare in control and
Chd7null mice (Fig. 6M, 6N), indicating that depletion of the
NSC pool is unlikely to be caused by NSC apoptosis. Further-
more, the number of apoptotic radial SGZ GFAP1 cells was
also very rare 8 months after TAM injection in GLAST::
CreERT2;Chd7f/f (Chd7null) and Cre-negative control mice (Fig.
6O).
To rule out the possibility that the NSC pool is depleted
through differentiation into astrocytes, adult GLAST::
CreERT2;Chd7f/f (Chd7null) and Cre-negative control mice were
stained with antibodies against the mature astrocyte marker
S100b 12 weeks and 8 months after TAM injection and the
number of astrocytes in the granular layer and hilus of the
DG counted. Chd7 deletion did not change the number of
mature astrocytes present in the DG at both timepoints (Fig.
6P, 6Q), suggesting that the stem cell pool is not depleted
due to differentiation of NSCs into astrocytes. Taken together,
our results are suggestive of a model whereby the NSC pool
is depleted primarily through the loss of NSC quiescence,
resulting in the premature conversion of stem cells into pro-
genitors, which fail to fully differentiate (Fig. 4G, 4H) and are
eliminated by apoptosis (Fig. 5E–5G).
CHD7 Regulates the Expression of Genes Involved in
Cell Cycle Progression and Notch Signaling
The findings presented so far identified CHD7 as an essential
regulator of NSC quiescence and showed that even a rela-
tively subtle loss of NSC quiescence can result in the deple-
tion of the NSC pool over time [13, 19]. As previous studies
have implicated cell cycle regulators and the Notch signaling
pathway in NSC quiescence and since the loss of cyclin-
dependent kinases and Notch signaling components result in
depletion of the NSC pool [13, 16–19], we hypothesized that
CHD7 might function upstream of these factors. To test this
hypothesis, RNA was extracted from the dentate gyri of
Chd7null and control mice and the expression of genes
involved in positive and negative cell cycle regulation assayed
by RT-qPCR. The expression of several genes encoding cyclins
and cyclin-dependent kinases, including Ccnb1, Ccnd2, Cdk1,
and Cdk2 were significantly upregulated in Chd7null samples
(Fig. 7A–7F). By contrast, the expression of the cell cycle
inhibitor, Btg1, was not affected by the loss of Chd7 (Fig. 7G)
[45, 46]. We also observed a significant increase in the
expression of Mtor, a key regulator of adult NSC quiescence
and proliferation [47, 48], in the Chd7null DG (Fig. 7H). Enge-
len et al. recently reported the genome-wide distribution of
CHD7 protein on chromatin in NSCs [27]. This study detected
significant enrichment of the Mtor promoter after CHD7 chro-
matin immunoprecipitation, thereby identifying Mtor as a
likely direct CHD7 target [27].
Reduced Notch signaling in adult NSCs results in the loss
of NSC quiescence and the eventual depletion of the stem
cell pool [15, 30, 49]. The Hes5 gene is a critical downstream
effector of Notch signaling in adult hippocampal NSCs [16, 18,
43, 50]. Data from Engelen et al. suggested that CHD7 is
recruited to the Hes5 gene promoter in NSCs. Together with
the demonstration that Hes5 expression is downregulated in
Chd71/- NSCs, these findings imply a direct role for CHD7 in
regulating Hes5 expression [27]. To determine whether CHD7
is required for normal levels of Hes5 expression in the adult
DG, we quantified the expression of Hes5. Microdissected DG
from Chd7null mice displayed a tendency for reduced Hes5
expression (Fig. 7I). As Hes5-expressing NSCs represent only a
small fraction of the total cells in the DG, we enriched for
NSCs by FACS-sorting GFP1 cells from GLAST::CreERT2;Chd7f/f;
RYFP/1 and GLAST::CreERT2;RYFP/1 mice 7 days after TAM
injection. Hes5 expression was significantly reduced in
Chd7null cells compared to controls (Fig. 7J), identifying CHD7
as a critical regulator of Hes5 expression.
To further examine the regulation of Hes5 by CHD7 we
analyzed the dynamics of Hes5 expression in NSCs during qui-
escence induction [33, 34]. Control NSCs rapidly upregulated
Hes5 expression upon exposure to quiescence medium (Fig.
7K). By contrast, Chd7null cells were unable to fully upregu-
late Hes5 expression (Fig. 7K), indicating that CHD7 is required
for Hes5 expression during quiescence. To find evidence that
CHD7 directly regulates Hes5 expression, a pcDNA::hChd7
expression construct was transfected into NSCs. RNA was
extracted from cells after incubation in growth media for 24
hours, or quiescence media for an additional 96 hours (Fig.
7L). Under growth conditions, the expression of Chd7
increased 3-fold in pcDNA::hChd7-transfected cells compared
to pcDNA-transfected controls but the expression of Hes5 was
unaffected (Fig. 7M), suggesting that under conditions that
force proliferation of NSCs, CHD7 expression is not sufficient
to induce Hes5 expression. However, under quiescence condi-
tions, CHD7 over-expression resulted in a 1.8-fold upregula-
tion of Hes5 expression (Fig. 7N). These results are consistent
with Hes5 being a direct and immediate target of CHD7 under
conditions that promote NSC quiescence.
To investigate the functional requirement of Hes5
expression in the context of CHD7 deficiency, we transfected
Chd7null cells with a pCLIG::rHes5 expression construct (rHe-
s5OX) or empty vector control. Cells were cultured in
growth media for 24 hours after transfection and then incu-
bated in quiescence media for a further 24 hours. RNA was
extracted or cells fixed and immunostained for Ki67 to
determine proliferation. rHes5 expression (Fig. 7O) was suffi-
cient to drive Chd7null cells into quiescence (Fig. 7P), show-
ing that Hes5 functions downstream of CHD7 to induce NSC
quiescence.
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Figure 7. CHD7 regulates NSC quiescence through the expression of cell cycle genes. (A–I): RT-qPCR expression level of Ccnb1 (A),
Ccnd1 (B), Ccnd2 (C), Ccne1 (D), Cdk1 (E), Cdk2 (F), Btg1 (G), Mtor (H), and Hes5 (I) from microdissected dentate gyrus (DG) of GLAST::
CreERT2;Chd7f/f (Chd7null) and Cre-negative control (Ctrl) mice 3 weeks after the tamoxifen (TAM) injection. Note a general increase in
the expression of many cell cycle genes. n5 4 animals (biological replicates) per condition. (J): RT-qPCR expression level of Hes5 in
YFP1Dapi- FACS-isolated NSCs from GLAST::CreERT2;Chd7f/f; RYFP/1 (Chd7null) and GLAST::CreERT2;RYFP/1 (Ctrl) mice 7 days after the
final TAM injection. n5 a minimum of 1000 cells from 4 animals per condition. (K): RT-qPCR expression level of Hes5 from cultured
fetal-derived NSCs from Nestin-Cre;Chd7f/f (Chd7null) and Cre-negative (control; Ctrl) embryos under growth conditions (T0) and after
incubation with media containing 50 ng/ml BMP4 (quiescence) for 24 (T24), 48 (T48), 72 (T72), and 96 (T96) hours, relative to ctrl. n 5
four reactions. (L): Schematic diagram of the experimental strategy to nucleofect Chd7-pcDNA [36] or pcDNA empty vector control into
control cells and extract the RNA from nucleofected cells under growth and quiescence conditions. (M, N): RT-qPCR expression level of
human Chd7 (which may also recognize mouse Chd7) and mouse Hes5 in Chd7-pcDNA and pcDNA control nucleofected cells after 24
hours in growth media (M) or 24 hours in growth media followed by 96 hours in quiescence media (N). (O, P): RT-qPCR expression of
rat Hes5 (which may also recognize mouse Hes5) (O) and quantification of cycling (Ki671) cells (P) in rHes5-pCLIG and pCLIG control
nucleofected Chd7null cells after 24 hours in growth media followed by 24 hours in quiescence media. All data represented as mean-
6 SEM; *, p< 0.05; **, p< 0.01; ***, p< 0.001 Student’s t test. (Q): Schematic diagram of the role of CHD7 in adult hippocampal NSC
quiescence. CHD7 maintains NSC quiescence by directly promoting the expression of Hes5 and inhibiting the expression of positive regu-
lators of cell cycle progression to maintain stem cell quiescence. Abbreviations: CHD7, chromodomain–helicase-DNA-binding protein 7;
NSC, neural stem/progenitor cells.
In summary, these data link pathways with established
roles in NSC quiescence to CHD7 (Fig. 7Q).
DISCUSSION
Several studies have suggested that the loss of stem cell qui-
escence in adult neurogenic niches can result in the prema-
ture depletion of the NSC pool [13, 15–20]. Preservation of a
quiescent state depends on the inhibition of genes involved in
cell cycle progression and the maintenance of genes encoding
cell cycle inhibitors. In the present study we have uncovered
a role for CHD7 in the maintenance of NSC quiescence and
differentiation of neuronal progenitors in the adult hippocam-
pus [26]. The loss of CHD7 in adult hippocampal stem cells is
associated with the increased expression of cyclins and cyclin-
dependent kinases involved in cell cycle progression (Fig. 6L).
Furthermore, the Notch effector gene, Hes5 is downregulated
upon CHD7 deletion. We propose that this combination of
gene expression changes together are responsible for the loss
of NSC quiescence in the absence of CHD7.
At present, it is unclear precisely how the regulation of
CHD7 expression is related to NSC quiescence. CHD7 levels
are clearly highest in activated, proliferative hippocampal neu-
ronal progenitors, both in vivo and in vitro (this study and
Feng et al. [26]). We propose that CHD7 expression is upregu-
lated as quiescent NSCs become activated and enter the cell
cycle and that this CHD7 upregulation is necessary for daugh-
ter cells to return to quiescence to maintain the NSC pool.
When Chd7null cells enter the cell cycle, our data suggest
that they would be unable to fully upregulate Hes5 expres-
sion. A failure to induce Hes5 expression might render these
cells unable to respond properly to Notch signals in the niche
leading to their reduced ability to return to quiescence.
Future studies to identify NSC dynamics in the intact stem
cell niche are required to test this model [3].
A recent study by Feng et al. showed that CHD7 is
required for neuronal differentiation by remodeling the pro-
moters of Sox4 and Sox11 to create an open chromatin state
[26]. SOX4 and SOX11 have been shown previously to play an
essential role in adult neurogenesis by binding directly to the
Dcx promoter and inducing its expression [51]. Interestingly,
we find that the number of DCX1 cells is not reduced shortly
after loss of Chd7, and is even increased 4 weeks after Chd7
deletion (Fig. 3B, 3L). These findings argue against a simple
model whereby CHD7 regulates neurogenesis primarily
through a SOX4/SOX11/DCX mechanism. It will be of signifi-
cant interest to identify the SOX4 and SOX11-regulated target
genes that mediate CHD7-dependent neuronal differentiation.
A recent study by Micucci et al. showed that CHD7 is
required for the self renewal of adult NSCs derived from the
subventricular zone (SVZ) of the lateral ventricles in vitro [25].
Furthermore, deletion of Chd7 from embryonic NSCs resulted
in a large decrease in SVZ proliferation in the perinatal SVZ
[25]. Micucci et al. could not detect any changes in the
expression of cell cycle regulators in the SVZ of Chd7-deficient
mice, in contrast to our findings in the hippocampus [25].
These differences may be reflected by the timing of TAM-
induced deletion of Chd7 (embryonic and adolescent com-
pared to adult), or may reflect differences in hippocampal
and olfactory bulb neurogenesis. Interestingly, Chd7null NSCs
in vitro can be passaged for many months (data not shown),
suggesting that in vitro, NSC self-renewal potential is not dra-
matically reduced in the absence of CHD7.
Our data, together with those showing CHD7 recruitment
to the Hes5 promotor [27], identify Hes5 as a key CHD7 target
required for NSC quiescence. Notch signaling is highly active
in adult NSCs and its persistence in adult neurogenic niches
has been shown to be essential for maintaining NSC quies-
cence [16, 18, 43]. Loss of Notch signaling has been shown to
cause the activation of NSCs, followed by a transient increase
in immature neuron formation and the eventual depletion of
the stem cell pool through replicative exhaustion [16–18]. The
similarities of these phenotypes to those described here upon
Chd7 deletion, lend support to the notion that CHD7 medi-
ates at least some of its effects through Hes5. Of note, Notch
signaling is key in maintaining quiescence in other somatic
stem cell systems, including in adult skeletal muscle satellite
cells [49, 52, 53] and pancreatic progenitors [54]. It is tempt-
ing to speculate that CHD proteins may have similar roles in
the maintenance of Notch signaling and quiescence in other
adult stem cell populations. Another key regulator of adult
NSC quiescence is BMP signaling, that can convert rapidly pro-
liferating NSCs in culture into a state of reversible quiescence
[33, 35]. Interestingly, a recent study has revealed an interac-
tion between CHD7 and the downstream BMP effectors
SMAD1/5/8 in embryonic cardiomyocytes [55]. It would be
interesting to examine the possibility that CHD7 regulates NSC
quiescence through an effect on BMP signaling.
Various critical roles for epigenetic regulators in stem cell
quiescence are beginning to emerge [56–58]. For example,
the chromatin remodeling enzyme CHD4 is required for hema-
topoietic stem cell (HSC) maintenance, through regulating the
expression of receptors that mediate interactions between
HSCs and their niche, and repressing Ccnd2 that drive HSC dif-
ferentiation [59]. The deletion of CHD4 in HSC populations
resulted in the loss of HSC quiescence and skewed their dif-
ferentiation potential to generate mainly erythroid cells [59].
Taken together with our data, these findings imply central
roles for chromatin remodeling factors in the maintenance of
a quiescent state in somatic stem cell populations.
We have shown that the NSC and progenitor cell pool is
reduced 8 months after deletion of Chd7. Feng et al. have
shown that exercise can rescue the neurogenesis defects in
CHD7 mutant mice [26]. The data presented here suggest that
interventions that enhance neurogenesis may only be of tem-
porary benefit as the Chd7-deficient NSC pool will eventually
become depleted due to the failure to maintain NSC quies-
cence, leaving few NSCs and daughter cells to respond to
exercise-induced neurogenesis. Therefore, treatments that pro-
mote NSC maintenance in addition to those that enhance
neurogenesis will be required to maintain sufficient levels of
neuronal production throughout life [60].
CONCLUSION
Hippocampal NSCs are mostly quiescent, a property critical
for the maintenance of the stem cell pool throughout life.
Loss of NSC quiescence was shown previously to cause a pre-
mature conversion of stem cells to lineage-restricted progeni-
tors and an eventual loss of neurogenesis and the NSC pool
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[15]. Here, CHD7 is identified as a critical regulator of NSC
quiescence in the adult hippocampus. We propose that CHD7
controls NSC quiescence through regulating the expression of
multiple genes involved in cell fate and proliferation. We have
identified Hes5 as one key CHD7 target gene through which
CHD7 maintains NSC quiescence.
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